RESUMEN
Squalestatin analogues modified at C3 were prepared and evaluated for their ability to inhibit rat liver microsomal squalene synthase in vitro. While the 4,6-dimethyloctenoate ester group at C6 was maintained, a number of modifications to the C3 carboxylic acid were well tolerated. However, in the absence of the C6 ester group, similar modifications to the C3 carboxyl group caused loss of activity. Selected compounds were evaluated for their ability to inhibit cholesterol biosynthesis in vivo in rats 1 and 6 h postadministration. Analogues of squalestatin 1 (S1) modified at C3 were found to possess a shorter duration of effect in vivo which is reflected in their substantially reduced ability to lower serum cholesterol levels in marmosets. Significant cholesterol lowering (up to 62%) for the C3 hydroxymethyl analogue 1b was observed only when this compound was dosed three times a day for 3 days.
Asunto(s)
Anticolesterolemiantes/farmacología , Compuestos Bicíclicos Heterocíclicos con Puentes/metabolismo , Compuestos Bicíclicos Heterocíclicos con Puentes/farmacología , Inhibidores Enzimáticos/farmacología , Farnesil Difosfato Farnesil Transferasa/antagonistas & inhibidores , Ácidos Tricarboxílicos/metabolismo , Ácidos Tricarboxílicos/farmacología , Animales , Anticolesterolemiantes/síntesis química , Anticolesterolemiantes/química , Compuestos Bicíclicos Heterocíclicos con Puentes/química , Callithrix/metabolismo , Colesterol/biosíntesis , Colesterol/sangre , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/química , Ésteres/síntesis química , Ésteres/farmacología , Microsomas Hepáticos/enzimología , Estructura Molecular , Ratas , Ácidos Tricarboxílicos/químicaRESUMEN
A series of squalestatins modified at the C3-position with a heterocyclic functionality was prepared and evaluated in vitro as inhibitors of squalene synthase (SQS). Structure-activity relationships for compounds with the 4,6-dimethyloctenoate at C6(S1 analogues) were different from those for analogues lacking the C6 ester (H1 analogues), with a greater dependence on the nature of the C3-substituent for the H1 series. Potent SQS inhibitory activity equivalent to that of H1 is retained by a C3-(tetrazol-5-yl) analogue, i.e., a carboxylic acid mimetic. The C3-methyl ester derivative is 10-fold less active than H1, and SQS inhibitory activity similar to that of the methyl ester was retained only in those C3-heterocycle-substituted H1 analogues for which electrostatic potential maps of the C3-substituent were closely similar to that of a methyl ester.
Asunto(s)
Compuestos Bicíclicos Heterocíclicos con Puentes , Compuestos Bicíclicos con Puentes/química , Farnesil Difosfato Farnesil Transferasa/antagonistas & inhibidores , Ácidos Tricarboxílicos/química , Animales , Compuestos Bicíclicos con Puentes/síntesis química , Compuestos Bicíclicos con Puentes/farmacología , Ésteres/química , Farnesil Difosfato Farnesil Transferasa/metabolismo , Hongos Mitospóricos/metabolismo , Modelos Moleculares , Ratas , Relación Estructura-Actividad , Ácidos Tricarboxílicos/síntesis química , Ácidos Tricarboxílicos/farmacologíaRESUMEN
Squalestatin analogues modified in the C1 side chain were prepared and evaluated for their ability to inhibit rat liver microsomal and Candida squalene synthase (SQS) in vitro. While maintaining the 4,6-dimethyloctenoate or 4,6-dimethyloctanoate ester groups at C6, a number of modifications to the C1 side chain were well tolerated. However, in the absence of the C6 ester group, similar modifications to the C1 side chain caused substantial loss of activity. Compounds were also evaluated for their ability to inhibit cholesterol biosynthesis in vivo in rats and to reduce serum cholesterol levels in marmosets. These studies revealed that compounds with similar SQS inhibitory activities can possess different in vivo durations of action and lipid-lowering abilities.
Asunto(s)
Compuestos Bicíclicos Heterocíclicos con Puentes , Compuestos Bicíclicos con Puentes/química , Farnesil Difosfato Farnesil Transferasa/antagonistas & inhibidores , Ácidos Tricarboxílicos/química , Animales , Anticolesterolemiantes/química , Anticolesterolemiantes/farmacología , Compuestos Bicíclicos con Puentes/farmacología , Callithrix , Candida albicans/enzimología , Colesterol/biosíntesis , Colesterol/sangre , Femenino , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Microsomas/enzimología , Microsomas Hepáticos/enzimología , Estructura Molecular , Ratas , Relación Estructura-Actividad , Ácidos Tricarboxílicos/farmacologíaRESUMEN
3,5-Dihydroxy-7-(N-imidazolyl)heptanoates 4 and the corresponding heptenoates 5 were synthesized as novel classes of potent HMG-CoA reductase (HMGR) inhibitors in which members of the latter series possess enzyme inhibitory activity greater than that of lovastatin 1 and pravastatin 2. Structure-activity studies show that the 7-(N-imidazolyl)heptenoates 5 are more active than the corresponding heptanoates 4. For both imidazolyl series, the 4-fluorophenyl group is preferred at C-5, and a broad range of aryl substituents which promote widely different lipophilicities is tolerated at C-4. While the CF3 group is preferred at C-2 in the heptanoate series, the 2-(1-methylethyl) substituent is optimal in the heptenoate series. The 2-(1-methylethyl) and 5-(4-fluorophenyl) groups can be interchanged in the latter series as exemplified by 5ab. Enzyme inhibitory activity resides principally in the 3R,5S series. These potent HMGR inhibitory activities by members of the heptenoate series translated well into whole cell activities in HepG2 cells. X-ray crystallographic studies on the active enantiomer 28 reveal noncoplanarity of the heptenoate C-C double bond with the imidazole ring; this finding provides an explanation for the high acid stability of the heptenoate series.
Asunto(s)
Colesterol/biosíntesis , Heptanoatos/síntesis química , Hidroxiácidos/síntesis química , Inhibidores de Hidroximetilglutaril-CoA Reductasas , Imidazoles/síntesis química , Animales , Cristalografía por Rayos X , Heptanoatos/farmacología , Hidroxiácidos/farmacología , Imidazoles/farmacología , Lovastatina/farmacología , Microsomas Hepáticos/enzimología , Estructura Molecular , Pravastatina/farmacología , RatasRESUMEN
A series of four isomeric 2'- and 6'-fluorocarbocyclic guanosine analogues have been prepared and evaluated as potential anti-herpes agents. The racemic 2' beta-fluoro isomer 2-amino-1,9-dihydro- 9-[(1 alpha, 2 alpha, 3 beta, 4 alpha)-2-fluoro-3-hydroxy-4- (hydroxymethyl)cyclopentyl]-6H-purin-6-one (11a, C-AFG) and its 2' alpha-fluoro epimer 11b plus the chiral 6' beta-fluoro isomer 2-amino-1,9-dihydro-9-[[1S-(1 alpha, 2 alpha, 3 alpha, 4 beta)]- 2-fluoro-4-hydroxy-3-(hydroxymethyl)cyclopentyl]-6H-purine-6-one (11c) and its 6' alpha-fluoro epimer 11d were prepared from their respective fluoro amino diol hydrochlorides (6a,d). For comparison, the furanosyl compound 9-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)guanine (17, AFG) was prepared by coupling 2-amino-6-chloropurine with 2-deoxy-2-fluoro-3,5-di-O-benzoyl-alpha- D-arabinofuranosyl bromide followed by base hydrolysis. The 6' alpha-fluoro derivative 11d exhibited comparable activity to that of acyclovir (ACV) against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro but was greater than 30-fold more active than ACV against HSV-1 and HSV-2 in vivo in the mouse systemic model. The 2' beta-fluoro derivative (11a, C-AFG) was extremely potent in vitro against HSV-1 and HSV-2 (ID50 0.006 and 0.05 micrograms/mL) and in vivo it was greater than 2 orders of magnitude more potent than ACV against HSV-1 and 70-fold more potent against HSV-2. The 2' alpha-fluoro 11b and 6' beta-fluoro 11c isomers were much less active.
Asunto(s)
Antivirales/síntesis química , Desoxiguanosina/análogos & derivados , Herpes Simple/tratamiento farmacológico , Simplexvirus/fisiología , Antivirales/química , Antivirales/uso terapéutico , Fenómenos Químicos , Química , Desoxiguanosina/síntesis química , Desoxiguanosina/química , Desoxiguanosina/farmacología , Desoxiguanosina/uso terapéutico , Espectroscopía de Resonancia Magnética , Estructura Molecular , Relación Estructura-Actividad , Replicación Viral/efectos de los fármacosRESUMEN
The racemic carbocyclic 2'-fluoroarabinosyl pyrimidine nucleosides 8, 9 (C-FIAU), 12, and 13 (C-FMAU) and the 2'-fluororibosyl pyrimidine nucleosides 17, 20, and 21 were prepared from their respective protected 2'-fluoro amino diols 5 and 14. The carbocyclic 2'-2'-difluorothymidine analogue 27 was obtained from the protected difluoro amino diol 24 which was prepared from the ketone 23 and (diethylamino)sulfur trifluoride (DAST). The chiral carbocyclic 2'-deoxy-6'-fluorouridines 33, 34, 38, and 39 were synthesized from the protected 6'-fluoro amino diols 30 and 36, which were prepared by reduction of the azides 28 and 35. C-FMAU (13) and C-FIAU (9) were active in vitro against HSV-1 with ID50 values of 4.4 and 11 micrograms/mL, respectively, but they were inactive against HSV-2. The cytidine analogues 12 and 20 displayed modest activity in vitro against HSV-1 and HSV-2 but were inactive against human influenza A virus.
Asunto(s)
Antivirales , Nucleósidos de Pirimidina/farmacología , Simplexvirus/efectos de los fármacos , Animales , Línea Celular , Fenómenos Químicos , Química , Cristalografía , Virus de la Influenza A/efectos de los fármacos , Espectroscopía de Resonancia Magnética , Conformación Molecular , Estructura Molecular , Nucleósidos de Pirimidina/síntesis química , Células Vero , Replicación Viral/efectos de los fármacosRESUMEN
Mycoplasma pulmonis, a pathogen of the respiratory tract in rats, was inoculated intracerebrally into neonate rats and hamsters to determine if it would induce lesions in the ependyma. Hydrocephalus was induced in 116 of 120 rats and in 23 of 28 hamsters. The severity of hydrocephalus was greater in the rats than in the hamsters. Hydrocephalus induction occurred only subsequent to inoculation of viable M. pulmonis. At 2 weeks of age, rats became refractory to induction of hydrocephalus. Light microscopy indicated that the hydrocephalus was communicating without an inflammatory response in the ventricles and meninges. Preliminary electron microscopy revealed that amorphous material covered portions of the ependymal surface and that cilia were sometimes matted together. It was suggested that the hydrocephalus was due to ciliary dysfunction or to an imbalance of cerebrospinal fluid secretion and absorption. This M. pulmonis-induced hydrocephalus may be a useful model for elucidating the pathogenesis of certain types of congenital hydrocephalus in humans.
Asunto(s)
Hidrocefalia/etiología , Mycoplasma , Envejecimiento , Animales , Anticuerpos Antivirales , Artritis/etiología , Encéfalo/ultraestructura , Membrana Celular/inmunología , Cricetinae , Femenino , Hidrocefalia/patología , Inyecciones Intravenosas , Mycoplasma/aislamiento & purificación , Embarazo , RatasRESUMEN
Baby hamster kidney cells were persistently infected with lymphocytic choriomeningitis (LCM) virus (BHKpi cells). After 21 passages of the BHKpi cells infectious virus could no longer be detected; however, the cultures continued to produce LCM virus particles which interfered with the replication of infectious LCM virus in BHKpi cells and protected mice from a subsequent intracranial inoculation of infectious LCM virus. Cultures of BHKpi cells appeared to consist of three cell populations: uninfected cells, infected cells containing infectious LCM virus, and infected cells releasing interfering particles of LCM virus.
Asunto(s)
Virus de la Coriomeningitis Linfocítica/crecimiento & desarrollo , Animales , Antígenos Virales/análisis , Línea Celular , Cricetinae , Virus de la Coriomeningitis Linfocítica/inmunología , Virus de la Coriomeningitis Linfocítica/aislamiento & purificación , Interferencia Viral , Replicación ViralRESUMEN
A 24-h neutralization test that is based on fluorescent cell counting was used for the detection and quantitative determination of serum-neutralizing antibody against lymphocytic choriomeningitis virus. The earliest manifestation of serum-neutralizing antibody in guinea pigs was shown to occur within 1 week after inoculation with lymphocytic choriomeningitis virus. Within 11 weeks, serum-neutralizing antibody increased from 20- to 300-fold. Neutralizing end points of serum samples, obtained from 3 through 11 weeks, were enhanced as much as sevenfold by complement. Anti-guinea pig immunoglobulin G or anti-whole guinea pig serum potentiated the neutralizing activity of serum as much as 20- and 40-fold, respectively.
Asunto(s)
Anticuerpos Antivirales/análisis , Formación de Anticuerpos , Coriomeningitis Linfocítica/inmunología , Virus de la Coriomeningitis Linfocítica/inmunología , Animales , Anticuerpos Antiidiotipos , Proteínas del Sistema Complemento , Cricetinae , Técnicas de Cultivo , Fibroblastos , Técnica del Anticuerpo Fluorescente , Cobayas/inmunología , Sueros Inmunes , Inmunoglobulina G , Riñón , Ratones , Pruebas de Neutralización , Cultivo de VirusRESUMEN
A quantitative assay for lymphocytic choriomeningitis virus was developed and standardized. The assay is based on direct immunofluorescent staining of infected L-929 cell monolayers and enumeration of cells containing fluorescent viral antigens. Maximal adsorption of virus to cells occurred within 1 h. Observations on the sequential development of viral antigens within cells showed that specific cytoplasmic fluorescence appeared within 10 h. The optimal time for enumerating fluorescent cells was from 18 to 20 h after addition of virus. A linear relationship was demonstrated between the number of infected cells and the relative virus concentration. Fluorescent cells were distributed randomly in infected cover slip cell monolayers. The immunofluorescent cell-counting assay for lymphocytic choriomeningitis virus was highly precise and reproducible.
Asunto(s)
Técnica del Anticuerpo Fluorescente/normas , Virus de la Coriomeningitis Linfocítica/aislamiento & purificación , Adsorción , Animales , Antígenos Virales , Recuento de Células , Estudios de Evaluación como Asunto , Células L , Métodos , Ratones , Cultivo de VirusRESUMEN
Depending on the concentration of actinomycin D, the yield of lymphocytic choriomeningitis virus in baby hamster kidney cells was either enhanced or inhibited.
Asunto(s)
Dactinomicina/farmacología , Virus de la Coriomeningitis Linfocítica/efectos de los fármacos , Animales , Línea Celular , Cricetinae , Riñón , Virus de la Coriomeningitis Linfocítica/crecimiento & desarrollo , Factores de Tiempo , Replicación Viral/efectos de los fármacosRESUMEN
The yields of the Armstrong and WE strains of lymphocytic choriomeningitis virus in baby hamster kidney (BHK) cells cultivated in either bovine, calf, fetal bovine, or horse serum were investigated. Lines of BHK cells were established in these sera. When the infected cell lines were observed by immunofluorescence, the per cent fluorescing cells for a given virus strain did not vary. However, for both strains, the extracellular virus yields per cell were significantly greater in the fetal bovine-cell line than in the other serum-cell lines.
Asunto(s)
Línea Celular , Sueros Inmunes/farmacología , Virus no Clasificados/crecimiento & desarrollo , Animales , Encéfalo/microbiología , Bovinos , Cricetinae , Medios de Cultivo , Técnica del Anticuerpo Fluorescente , Cobayas , Caballos , Riñón , Virus de la Coriomeningitis Linfocítica/efectos de los fármacos , Virus de la Coriomeningitis Linfocítica/crecimiento & desarrollo , Virus de la Coriomeningitis Linfocítica/aislamiento & purificación , Ratones , Conejos , Replicación ViralAsunto(s)
Animales , Encéfalo , Línea Celular , Embrión de Pollo , Medios de Cultivo , Efecto Citopatogénico ViralRESUMEN
Infection of BHK-21 cells with lymphocytic choriomeningitis (LCM) virus resulted in the production of significant titers of complement-fixing (CF) antigen. The antigen was spontaneously released from the cells, but the highest titer of 1:16 was recovered by disruption of the infected cells by freeze-thawing in tryptose phosphate broth. The antigen could be partially separated from infectious virus by centrifugation. Furthermore, it was possible to detect LCM virus infection of cell cultures by the production of the CF antigen, but this method proved less sensitive than titration by intracerebral inoculation of mice. The CF antigen from cell cultures was at least as sensitive and specific as the reference antigen prepared from infected guinea pig spleen.